Publication | Closed Access

In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein–Barr nuclear antigen-1, strongly cross-react with the peptide β60-74Cit which bears the immunodominant epitope of citrullinated fibrin

Clinical ImmunologyImmunohematologyImmunodeficienciesImmunologyImmune RegulationPathologyCitrullinated FibrinImmune SystemAutoantibodiesRheumatoid ArthritisRheumatologyAutoimmune DiseaseAutoimmunityImmunologic DiseaseImmune-mediated Inflammatory DiseasesImmune FunctionCitrullinated PeptideAcpa-positive Ra PatientsMedicine